PhoreMost
Cambridge, GB Β· 4 known investors
PhoreMost is a biotechnology company developing small molecule drugs and targeted protein degradation therapeutics for cancers with high unmet clinical need, with a lead program (PMC-001) for primary and metastatic brain cancers in Phase 1/2a clinical evaluation.
BiotechMedical Devices
Investors Β· 4
Frequently asked questions
- What does PhoreMost do?
- PhoreMost is a biotechnology company developing small molecule drugs and targeted protein degradation therapeutics for cancers with high unmet clinical need, with a lead program (PMC-001) for primary and metastatic brain cancers in Phase 1/2a clinical evaluation.
- Who are PhoreMost's investors?
- PhoreMost's investors include Amadeus Capital Partners, Astellas Venture Management LLC, Cambridge Angels group, University of Cambridge Enterprise.
- Where is PhoreMost headquartered?
- PhoreMost is headquartered in Cambridge, GB.